Clinical Trials Browser

Phase 3 × Recruiting × Letrozole × Clear all

NCT06072781 2026-03-17

RAMP 301

Phase 3 Recruiting

Low Grade Serous Ovarian Cancer

NCT07085767 2026-03-16

OPERA-02

Phase 3 Recruiting

Breast Neoplasms

NCT06016738 2026-03-13

OPERA-01

Phase 3 Recruiting

Breast Neoplasms

NCT06790693 2026-03-06

INAVO123

Phase 3 Recruiting

Breast Neoplasms

NCT07174336 2026-03-06

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Phase 3 Recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT04852887 2026-03-03

DEBRA

Phase 3 Recruiting

Breast Neoplasms

NCT05827081 2026-03-02

Adjuvant WIDER

Phase 3 Recruiting

Breast Neoplasms, Breast Neoplasms, Male

NCT06760637 2026-03-02

FourLight-3

Phase 3 Recruiting

Unilateral Breast Neoplasms, Breast Neoplasms, Recurrence

NCT06507618 2026-02-24

POWER II

Phase 3 Recruiting

Breast Neoplasms

NCT07019363 2026-01-21

CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS)

Phase 3 Recruiting

Breast Neoplasms

NCT04111978 2025-09-29

MATAO

Phase 3 Recruiting

Fallopian Tube Neoplasms, Peritoneal Neoplasms

NCT05512364 2025-08-19

TREAT ctDNA

Phase 3 Recruiting

Breast Neoplasms

NCT05952557 2025-06-19

CAMBRIA-2

Phase 3 Recruiting

Breast Neoplasms

NCT03011684 2025-05-08

TALES

Phase 3 Recruiting

Breast Neoplasms, Infertility

NCT06418347 2025-02-24

Effect of ALA Combined With Letrozole on Polycystic Ovary Syndrome Clinical Outcome in Infertile Females

Phase 3 Recruiting

Infertility, Infertility, Female, Polycystic Ovary Syndrome

NCT05601700 2025-01-27

LEPRE

Phase 3 Recruiting

Carcinoma, Ovarian Epithelial

NCT05891093 2024-02-08

Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)

Phase 3 Recruiting

Breast Neoplasms

NCT05851014 2023-05-09

A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

Phase 3 Recruiting

Breast Neoplasms

NCT05780567 2023-04-21

Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer

Phase 3 Recruiting

Breast Neoplasms